US 12006364
Anti-CD100 antibodies and methods for using the same
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 12006364 (Anti-CD100 antibodies and methods for using the same) held by VACCINEX, INC. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K39/0001, A61K39/3955